The PhenomenonA World Seized by AI FOMO

A peculiar anxiety has settled over offices, classrooms, and dinner tables alike. Call it AI FOMO — the fear of being left behind by artificial intelligence. Every week brings another headline: a new model, a new capability, another profession supposedly on the verge of disruption. In response, millions of people are rushing to sign up for AI tools, sharing sensitive queries with chatbots, uploading private documents for summarisation, and granting broad data permissions without reading a single line of the terms of service.

The frenzy is understandable. When a technology promises to rewrite the rules of productivity, creativity, and even competitive advantage, the rational fear is being the last one to arrive at the party. But in this particular race, the entry fee is often paid in the currency most people undervalue until it is gone: personal data and privacy.

The Business LogicWhy Tech Companies Need Your Data

To understand the risk, one must first understand the incentive. AI systems — particularly large language models (LLMs) — require enormous quantities of diverse, high-quality data to improve. The commercial logic is straightforward: the richer and more varied the training data, the more capable the model; the more capable the model, the more attractive the cloud and AI products built on top of it; the more attractive those products, the higher the revenue.

This creates a powerful structural pressure for tech companies to harvest as much free user data as possible. Casual conversations, uploaded files, search queries, voice recordings, health check-ins — each interaction is a potential data point. Some companies are transparent about this data use; others bury consent language in lengthy agreements that few users ever read. Either way, the flow of data from user to corporation is vast, largely invisible, and often irreversible.

Critical InfrastructureHealthcare and Life Sciences at the Fault Line

If data privacy is the general problem, the healthcare and life sciences sectors represent its most acute expression. Medical records are the most intimate documentation of a human life — diagnoses, medications, mental health histories, genetic predispositions. They are also extraordinarily valuable. On dark web markets, a single complete health record can fetch many times the price of a credit card number, precisely because the information is so sensitive and so permanent.

Pharmaceutical companies, hospital networks, and biotech firms are under immense pressure to integrate AI into drug discovery, diagnostics, and patient management. Many are doing so at speed, grafting new AI tools onto legacy IT infrastructure that was never designed with modern threat models in mind. The result is an expanding attack surface: more entry points, more data in motion, and often insufficient security governance keeping pace with the technology adoption.

A successful breach in this context does not merely expose financial information that can be cancelled and reissued. It can expose a patient’s HIV status, psychiatric history, or genetic risk factors — information that cannot be changed and that carries profound implications for insurance, employment, and personal safety. The stakes are categorically different from a leaked password.

What To DoA Practical Guide for Individuals, Businesses, and Governments

None of this is an argument against using AI. The technology offers genuine and substantial benefits. The argument is for using it with eyes open — understanding what is being exchanged, with whom, and under what conditions. Below are concrete directions for each level of society.

For individuals, the most powerful tool is deliberate slowness. Before adopting a new AI service, ask: What data does it collect? Who owns that data? Is this free tier actually free, or is user data the revenue model? Read privacy policies — or at minimum, use tools that summarise them. Compartmentalise: use different accounts and devices for sensitive queries. Never enter identifiable personal, financial, or medical information into an AI chatbot unless you have verified how that data is handled.

For businesses, the imperative is governance before adoption. No AI tool should be deployed in a production environment — especially one touching customer data — without a formal data protection impact assessment. Employees need clear, practical training: not a one-hour compliance video, but ongoing, role-specific guidance on which AI tools are approved, which are prohibited, and why. Contracts with AI vendors must specify data retention, deletion, and audit rights explicitly.

Healthcare and pharmaceutical organisations bear a particular responsibility. Cybersecurity posture must be assessed and hardened before AI integration, not after a breach. Network segmentation, zero-trust architectures, and regular penetration testing are not optional extras — they are baseline requirements when the data being protected belongs to patients who had no meaningful choice about sharing it.

For governments, the priority is regulatory clarity at speed. AI development is outrunning the frameworks designed to govern it. Data protection laws written before the current generation of LLMs are insufficient for the current landscape. Regulators need to establish clear rules on what data can be used to train commercial AI models, what consent standards apply, and what remedies exist when breaches occur. International coordination matters enormously: data does not respect borders, and regulatory arbitrage — companies basing their data operations wherever rules are weakest — is already a live problem.

The Bigger PictureSlowness as a Form of Wisdom

The AI FOMO narrative is, in many ways, a constructed one. The companies most eager to accelerate adoption are often the same ones who benefit most from the data that adoption generates. The urgency is real in some domains, but in many everyday contexts, the cost of waiting six months to adopt a new tool — and using that time to understand it properly — is near zero. The cost of granting sweeping data permissions to an unvetted service can last a lifetime.

Technology adoption has always carried a tradeoff between the early-mover advantage and the cost of being an early-mover guinea pig. In the AI era, that cost is measured not just in buggy software experiences, but in the permanent surrender of sensitive personal information to commercial entities whose long-term incentives may not align with individual welfare.

The question is not whether to engage with AI. The question is whether engagement can be made thoughtful, conditional, and informed. That requires individuals to slow down, businesses to build proper governance, and governments to act with the urgency they currently reserve for economic competition rather than citizen protection.